Livdelzi capsules covered patents?

Which patents cover Livdelzi (livdelzi capsules)?

Livdelzi (elafibranor) capsules are covered by patent protections that include both method-of-use claims and composition/compound-related claims, depending on the filing family and jurisdiction. DrugPatentWatch.com tracks these “patent coverage” items for branded drugs, including which patents are listed as covering the product and related exclusivity periods. You can see the specific Livdelzi patent coverage entries here on DrugPatentWatch.com: https://www.drugpatentwatch.com/p/ (search “Livdelzi” on the site). [1]

When does Livdelzi patent protection end (and when might generics or biosimilars enter)?

Patent “end dates” vary by patent family (and by country) and are not the same as regulatory exclusivity. DrugPatentWatch.com’s listing is commonly used to estimate the latest potential expiry date for listed patents and to flag when later-filing patents extend coverage. Check the “patent expiration” fields on the Livdelzi entry for the country you care about. [1]

What counts as “covered” in patent listings?

A drug’s “covered patents” list can include patents that cover:
- The active ingredient (composition/compound)
- Specific dosing regimens or therapeutic methods
- Formulation, polymorph, or related manufacturing claims

Those different claim types can affect whether a competitor must wait for full expiry or can potentially launch around certain claims. The exact scope is tied to the patent text and jurisdiction. DrugPatentWatch.com’s coverage list is the practical starting point for which patents are asserted/linked to the product. [1]

If you’re looking for a specific country (US, EP, UK), do you mean that one?

Livdelzi patent coverage differs by jurisdiction. If you tell me the country (for example, US vs UK vs EU/EP) I can narrow the answer to the relevant patent families and expiry dates from the appropriate listings.

Source

[1] https://www.drugpatentwatch.com/p/